Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Uterine Cervix Cancer: early-phase trial registry

1 of 2 indexed Uterine Cervix Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Uterine Cervix Cancer: 2 US clinical trials tracked, 1 recruiting.

Uterine Cervix Cancer is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Denise Fabian, running 2 of these trials.

Enrollment posture brief

Registry condition uterine-cervix-cancer

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Uterine Cervix Cancer (this)50%
Open-enrollment share among volume-matched conditions near Uterine Cervix Cancer

Uterine Cervix Cancer lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Uterine Cervix Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Uterine Cervix Cancer is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Denise Fabian 2 trials

Named interventions

Most-linked intervention names on Uterine Cervix Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Standard Radiation
1 trials
high-dose-rate (HDR) brachytherapy Radiation
1 trials
intensity modulated radiation therapy (IMRT) Radiation
1 trials
Cisplatin Drug
1 trials

US sites by state

Facility locations filed on Uterine Cervix Cancer trials. A trial with sites in several states counts in each.

Kentucky 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Uterine Cervix Cancer page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Uterine Cervix Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Denise Fabian sponsors the most Uterine Cervix Cancer trials on record, review their full trial history before evaluating a specific study. See Denise Fabian's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Uterine Cervix Cancer condition card totals 2 registered trials; most-linked intervention Standard; top US site state Kentucky. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.